Literature DB >> 1708306

Inhibition of CRH-41 release by substance P, but not substance K, from the rat hypothalamus in vitro.

M Faria1, P Navarra, S Tsagarakis, G M Besser, A B Grossman.   

Abstract

Substance P is one of a series of tachykinins which is present throughout the central nervous system, and has potent effects on neuroendocrine function. Recent studies have suggested that it inhibits pituitary-adrenal activity at a site above the level of the pituitary. We have therefore used a well-validated rat hypothalamic incubation system to investigate the effects of substance P on the release of the principal corticotrophin-releasing hormone, CRH-41. Substance P caused a dose-dependent inhibition of the 28-mM KCl-stimulated release of CRH-41, with a maximum effect at 100 nM (P less than 0.01). This effect was attenuated by 10 microM of the substance P antagonist (D-Pro2,-D-Trp7,9)-substance P. No statistically significant effect of substance K was seen at 1 or 100 nM. Substance P, at a dose of 100 nM, did not alter the 28-mM KCl-stimulated release of CRH-41 from isolated median eminences in vitro. It is concluded that substance P is a potent inhibitor of the stimulated release of CRH-41, probably acting at a site within the hypothalamic paraventricular nucleus.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1708306     DOI: 10.1016/0006-8993(91)90378-9

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  2 in total

1.  The effect of restraint stress on the normal colon and on intestinal inflammation in a model of experimental colitis.

Authors:  Eran Israeli; Tiberiu Hershcovici; Eduard Berenshtein; Giulliana Zannineli; Dov Wengrower; Ofra Weiss; Mordechai Chevion; Eran Goldin
Journal:  Dig Dis Sci       Date:  2007-06-13       Impact factor: 3.199

Review 2.  Mechanisms by which Stress Affects the Experimental and Clinical Inflammatory Bowel Disease (IBD): Role of Brain-Gut Axis.

Authors:  Bartosz Brzozowski; Agnieszka Mazur-Bialy; Robert Pajdo; Slawomir Kwiecien; Jan Bilski; Malgorzata Zwolinska-Wcislo; Tomasz Mach; Tomasz Brzozowski
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.